First Patient Dosed in CAR T-Cell Therapy/Pembrolizumab Trial for Colorectal Cancer

Further details on the KEYNOTE-B79 trial were presented at the 2022 ASCO GI Symposium.

Improving Outcomes in Corneal Endothelial Disease With Cell Therapy

Greg Kunst, chief executive officer, Aurion Biotech, discussed the potential of cell therapy in treating people with corneal endothelial disease around the world.

Around the Helix: Gene and Cell Therapy Company Updates - January 19, 2022

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in gene and cell therapies.

Trial Initiated for Pediatric Liver Cancer Cell Therapy

The phase 1/2 ARYA-2 trial will be run in parallel with the similar phase 1/2 ARYA-1 and ARYA-3 trials.

Cilta-Cel's Efficacy in Heavily Pretreated Patients With Multiple Myeloma: Thomas G. Martin, MD

The clinical professor of medicine, Helen Diller Family Comprehensive Cancer Center, UCSF, discussed data from the CARTITUDE-1 study presented at ASH 2021.

FDA Extends BLA Review for bluebird bio’s β-Thalassemia and CALD Gene Therapies

Eli-cel remains on clinical hold in cerebral adrenoleukodystrophy after a report of persistent anemia.